GlassScriptPhysician profile
Vekash Raja
NPI 1437722816
$3,153.66
in general payments reported to CMS, 2019-2025
8 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,317 · 2024: $1,488 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,422 · Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,421.86 |
| Food and Beverage | $731.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,720.85 | 2023-2024 | Vercise |
| Abbott Laboratories | $136.25 | 2025 | Infinity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.64 | 2025 | Caplyta |
| Acadia Pharmaceuticals INC | $64.17 | 2023 | Nuplazid |
| Jazz Pharmaceuticals INC. | $55.37 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $46.80 | 2025 | Abilify Maintena, Rexulti |
| Alkermes, INC. | $27.25 | 2025 | Aristada, Lybalvi |
| Abbvie INC. | $20.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vekash Raja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.